Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

Latha Soorya, Jessica Kiarashi, Eric Hollander

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

Original languageEnglish (US)
Pages (from-to)753-771
Number of pages19
JournalChild and Adolescent Psychiatric Clinics of North America
Volume17
Issue number4
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Citalopram
Serotonin Uptake Inhibitors
Fluvoxamine
Sertraline
Risperidone
Fluoxetine
Valproic Acid
Oxytocin
Neuropeptides
Research
Autism Spectrum Disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health

Cite this

Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders. / Soorya, Latha; Kiarashi, Jessica; Hollander, Eric.

In: Child and Adolescent Psychiatric Clinics of North America, Vol. 17, No. 4, 10.2008, p. 753-771.

Research output: Contribution to journalArticle

@article{d7f1f6061e4e4c838d0bdd9389f515a2,
title = "Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders",
abstract = "This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.",
author = "Latha Soorya and Jessica Kiarashi and Eric Hollander",
year = "2008",
month = "10",
doi = "10.1016/j.chc.2008.06.003",
language = "English (US)",
volume = "17",
pages = "753--771",
journal = "Child and Adolescent Psychiatric Clinics of North America",
issn = "1056-4993",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

AU - Soorya, Latha

AU - Kiarashi, Jessica

AU - Hollander, Eric

PY - 2008/10

Y1 - 2008/10

N2 - This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

AB - This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

UR - http://www.scopus.com/inward/record.url?scp=50449087037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50449087037&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2008.06.003

DO - 10.1016/j.chc.2008.06.003

M3 - Article

C2 - 18775368

AN - SCOPUS:50449087037

VL - 17

SP - 753

EP - 771

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

SN - 1056-4993

IS - 4

ER -